Novo Nordisk CEO Lars Sorensen Named World's 'Best-Performing CEO' | Fortune
Jean-Paul Clozel
Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges
Jean-Paul Clozel | EY - Global
Deux stars de la biotech suisse réussissent une brillante entrée en bourse | 24 heures
Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
Idorsia will take three to four years to reach profitability, CEO says
Bilanz 300 Reichste 2022: Jean-Paul und Martine Clozel | BILANZ
Jean-Paul Clozel
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma
Les 500 plus grandes fortunes de France en 2022 - Challenges
CEO Daily: Thursday, 26th January | Fortune
New Suitor Reportedly Replaced J&J in This $20 Billion Biotech Deal | Fortune
Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France
Profile: Jean-Paul Clozel | Nature Biotechnology
Novo Nordisk CEO Lars Sorensen Named World's 'Best-Performing CEO' | Fortune
From Actelion to Idorsia: The entrepreneurial journey of Jean-Paul Clozel & Martine Clozel
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
PharmaBoardroom - Jean-Paul Clozel - CEO & Co-Founder, Actelion, Switzerland
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
World Entrepreneur 2008Dr Jean -Paul Clozel with wife Mart… | Flickr
Jean-Paul Clozel
La Suisse a vu, en 2017, plus de milliardaires partir qu'arriver - SWI swissinfo.ch
